Universitätsklinikum Halle
Halle 6120
1 studies enrolling now · 12 studies all time
What they study most
AML, Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN), Adult Acute Myeloid Leukemia, Advanced Hepatocellular Carcinoma (HCC), Aortic Valve Stenosis, Cardiovascular Diseases, Heart Diseases, Heart Valve Diseases, Lesion in Body Region, Leukemia, Myelomonocytic, Chronic, Myelodysplastic Syndromes, Refractory Hodgkin Lymphoma
Studies at this site
- Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT — Recruiting now
- A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma — Running, not enrolling
- A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
- Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS — Completed
- Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI) — Completed
- A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC — Stopped early
- Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs — Completed
- Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed
- An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) — Stopped early
- JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study — Status unconfirmed
- (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive — Completed
- A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis — Completed